
Senior Scientist, Quality Control, Microbiology
Job Overview
Location
Sacramento, CA
Job Type
Full-time
Category
Product Management
Date Posted
September 16, 2025
Full Job Description
đź“‹ Description
• Serve as the definitive microbiology authority for Orca Bio’s GMP cell-therapy facility, ensuring every batch of our high-precision investigational products meets the sterility and safety standards that give blood-cancer patients a second chance at life.
• Own the design, validation, and continuous improvement of viable and non-viable environmental-monitoring (EM) programs for ISO-classified cleanrooms, production equipment, and personnel; align all protocols with USP <1116>, EU GMP Annex 1, FDA/EMA guidance, and internal risk assessments.
• Lead method-development and qualification studies for rapid microbial detection, endotoxin, bioburden, sterility, and mycoplasma assays; author robust validation protocols, technical reports, and SOPs that withstand regulatory scrutiny and scale seamlessly from Phase II to commercial launch.
• Interpret complex EM and utility data sets, apply statistical process-control tools, and present clear, risk-based recommendations to senior leadership; drive CAPA effectiveness and proactively prevent excursions that could delay patient dosing.
• Act as the primary microbiology subject-matter expert during FDA, EMA, and partner audits; respond to agency questions in real time, defend data-integrity practices, and transform observations into sustainable compliance enhancements.
• Investigate all microbiological deviations, out-of-specification results, and environmental excursions using root-cause methodologies such as fishbone diagrams, 5-Whys, and fault-tree analysis; author thorough investigation reports and mentor junior staff in sound scientific writing.
• Partner cross-functionally with Manufacturing, QA, Facilities, MSAT, and Process Development to embed contamination-control strategies into facility design, equipment qualification, and batch records; influence upstream decisions that reduce microbial risk downstream.
• Establish and maintain a risk-based contamination-control program that includes cleaning validation, disinfectant efficacy, personnel monitoring, and raw-material assessments; ensure strategies evolve with emerging regulatory expectations and novel therapy modalities.
• Provide hands-on training, coaching, and technical guidance to QC Microbiology analysts and manufacturing operators; build a culture where every team member understands the “why” behind aseptic technique and environmental stewardship.
• Champion continuous-improvement initiatives—lean lab workflows, paperless data systems, automation opportunities—that shorten testing turnaround times and free scientists to focus on higher-value investigations.
• Contribute to regulatory filings (IND, IMPD, BLA) by authoring CMC sections, risk assessments, and comparability protocols that articulate microbiological control strategies and product safety.
• Maintain full data-integrity compliance with ALCOA+ principles; perform periodic data reviews, laboratory audits, and training refreshers to ensure inspection readiness at all times.
• Support tech-transfer of new products into the Sacramento facility by defining microbiological control points, acceptance criteria, and sampling plans that align with process capabilities and patient safety.
• Participate in cross-site networks to harmonize microbiology practices, share lessons learned, and implement global standards that position Orca Bio as a leader in cell-therapy manufacturing.
• Model Orca Bio’s core values—passion, courage, and integrity—by asking “why not?” and challenging the status quo in pursuit of breakthrough therapies that restore patients’ lives.
Skills & Technologies
Senior
Remote
Degree Required
About Orca Bio, Inc.
Orca Bio is a clinical-stage cell therapy company developing high-precision allogeneic stem cell and T-cell therapeutics to treat blood cancers, genetic disorders and autoimmune diseases. Its proprietary Orca-Q platform enables precise purification and formulation of donor-derived cell subsets to reduce graft-versus-host disease and improve engraftment outcomes. The company is advancing multiple Phase 2/3 trials in hematopoietic stem cell transplantation and has partnerships with leading transplant centers to commercialize next-generation cellular medicines.
Similar Opportunities
Pisa Milan Collecchio Roma Any
Full-time
Onsite
Degree Required
9 days ago